Investigation of an LPA KIV-2 nonsense mutation in 11,000 individuals: the importance of linkage disequilibrium structure in LPA genetics.
Silvia Di MaioiD, Rebecca GrüneisiD, Gertraud StreiteriD, Claudia LaminaiD, Manuel MaglioneiD, Sebastian SchönherriD, Dietmar ÖfneriD, Barbara ThorandiD, Annette PetersiD, Kai‐Uwe EckardtiD, Anna KöttgeniD, Florian KronenbergiD, Stefan CoassiniD
Abstract
ObjectiveElevated Lp(a) plasma concentrations are determined mainly genetically by the LPA gene locus, but up to 70% of the coding sequence is located in the so-called "kringle IV type 2" (KIV-2) copy number variation. This region is not resolved by common genotyping technologies and large epidemiological studies on this region are therefore missing. The Arg21Ter variant (R21X, variant frequency {approx}2%) is a functional variant in this region, but it has never been analyzed in large cohorts and is it unknown whether it is captured by genome-wide association studies. Approach and ResultsWe developed a highly sensitive allele-specific qPCR assay and genotyped R21X in 10,910 individuals from three populations (GCKD, KORA F3, KORA F4). R21X carriers showed significantly lower mean Lp(a) concentrations (-11.7 mg/dL [-15.5;-7.82], p=3.39e-32). Of particular note, virtually all R21X carriers also carried the splice mutation rs41272114 (D=0.957, R2=0.275), as confirmed by pulsed-field gel electrophoresis and long-range haplotyping. This proposes that the R21X mutation arose on the background of the rs41272114 splice variant. ConclusionsWe performed the largest epidemiological study on an LPA KIV-2 variant so far. Interestingly, R21X is located on the same haplotype as the splice mutation rs41272114, creating "double-null" LPA alleles that are inactivated by two independent mutations. The effect of the R21X nonsense mutation can thus not be discerned from the effect of rs41272114 splice site mutation. This emphasizes the importance of assessing the complex LD structure within LPA even for functional variants.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 40
- FWCI
- 4.34
- Field percentile
- top 4%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing
Raphael O. Betschart, Georgios Koliopanos, … Andreas Ziegler·BioMedPeer-reviewed·Jun 4, 2024
- Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries
Seyedeh Maryam Zekavat, Sanni Ruotsalainen, … Brian Custer·Nature CommunicationsPeer-reviewed·Jun 28, 2018
- A pan-genome approach to decipher variants in the highly complex tandem repeat of LPA
Chen-Shan Chin, Sairam Behera, … Fritz Joachim Sedlazeck·bioRxiv·Jun 8, 2022
- Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson disease
Mie Rizig, Oluwadamilola Omolara Ojo, … Njideka Ulunma Okubadejo·Neurobiology of AgingPeer-reviewed·Oct 1, 2020
- A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
Natalie Telis, Hang Dai, … Kelly M. Schiabor Barrett·medRxiv·Nov 1, 2024
- Analysis of reproductive traits associated with lipoprotein(a) deficiency in participants from the Pakistan Genome Resource
Christopher Koch, Center for Non?Communicable Diseases (CNCD) ? Pakistan, … Danish Saleheen·bioRxiv·Nov 6, 2026